About
Nadav Eshkol is an Israeli biotech operations executive focused on cell therapy process development, scale-up, tech transfer, and manufacturing. He is VP Operations at Minovia Therapeutics, a mitochondrial therapy company positioning its platform across rare mitochondrial disease and longevity applications. Before Minovia, he held development and manufacturing leadership roles at Pluristem Therapeutics and was previously a process engineer at TowerJazz.
Areas of interest
biotechcell therapymitochondrial medicinemanufacturingprocess developmentlongevity